Moolec Science (MLEC) Gross Profit (2023 - 2024)
Moolec Science's (MLEC) quarterly Gross Profit came in at -$674369.0 in Q4 2024, down 390.58% year-on-year from $232074.0 in Q1 2024, and down 4664.88% quarter-over-quarter from $14773.0 in Q3 2024.
Moolec Science (MLEC) Gross Profit (2023 - 2024) Analysis & Trends
Moolec Science has disclosed Gross Profit across 2 years of filings, most recently posting -$674369.0 for Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -674,369.00 |
| Dec 31, 2024 | -674,369.00 |
| Sep 30, 2024 | 14,773.00 |
| Sep 30, 2024 | 14,773.00 |
| Mar 31, 2024 | 91,743.00 |
| Mar 31, 2024 | 91,743.00 |
| Dec 31, 2023 | 232,074.00 |
| Dec 31, 2023 | 232,074.00 |
| Sep 30, 2023 | 220,408.00 |
| Sep 30, 2023 | 220,408.00 |